Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Pigmentation01:19

Pigmentation

The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Cells of the Epidermis01:24

Cells of the Epidermis

The epidermis is made of four or five layers of epithelial cells, depending on its location in the body. From deep to superficial, these layers are the stratum basale, stratum spinosum, stratum granulosum, stratum lucidum, and stratum corneum.
The cells in all these layers except the stratum basale are called keratinocytes, a type of cell that manufactures and stores the protein keratin. The keratinocytes in the stratum corneum are dead and regularly slough away, being replaced by cells from...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years.

Nature communications·2026
Same author

Strengthening Biomarker Research in Canadian Cancer Clinical Trials: A Pathology-Focused White Paper.

Current oncology (Toronto, Ont.)·2026
Same author

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment - update 2026.

European journal of cancer (Oxford, England : 1990)·2026
Same author

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention - Update 2026.

European journal of cancer (Oxford, England : 1990)·2026
Same author

The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection.

Ecancermedicalscience·2026
Same author

The impact of next generation sequencing studies on the diagnosis of BAP1 inactivated melanocytic tumors.

Human pathology·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: May 7, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

El melanoma cutáneo es

Alexander M M Eggermont1, Alan Spatz2, Caroline Robert3

  • 1Melanoma Unit and INSERM U981, Gustave Roussy Cancer Institute, Grand Paris, Villejuif, France; Erasmus University Medical Centre, Rotterdam, Netherlands.

Lancet (London, England)
|September 24, 2013
PubMed
Resumen

Los avances en la investigación del melanoma incluyen nuevos genes y terapias dirigidas como los inhibidores de BRAF. Si bien los tratamientos mejoran la supervivencia, el pronóstico del melanoma metastásico sigue siendo pobre, lo que pone de relieve la necesidad de mejores biomarcadores e inmunoterapias.

Más Videos Relacionados

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

Videos de Experimentos Relacionados

Last Updated: May 7, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

Área de la Ciencia:

  • Oncología Oncología Oncología.
  • Dermatología Dermatología dermatología.
  • Inmunología Inmunología.

Sus antecedentes:

  • Progreso significativo en la comprensión de la genética y el tratamiento del melanoma en la última década.
  • Las mutaciones BRAF son eventos somáticos clave que influyen en las estrategias terapéuticas para el melanoma.

Objetivo del estudio:

  • Revisar los avances recientes en la comprensión, el tratamiento y el pronóstico del melanoma.
  • Discutir las terapias emergentes, incluida la inmunomodulación y las combinaciones de fármacos específicos.
  • Para resaltar la búsqueda en curso de biomarcadores predictivos en el tratamiento del melanoma.

Principales métodos:

  • Revisión de la literatura científica reciente sobre el melanoma.
  • Análisis de los enfoques de tratamiento quirúrgico y sistémico.
  • Evaluación de las inmunoterapias (anti-CTLA4, anti-PD1, anti-PDL1) y las terapias dirigidas (inhibidores BRAF, MEK).

Principales resultados:

  • La cirugía es estándar para el melanoma localizado; la biopsia de nodo centinela ayuda a la estadificación pero no a la supervivencia.
  • Las terapias dirigidas (inhibidores de BRAF / MEK) muestran altas tasas de respuesta, pero durabilidad limitada debido a la resistencia.
  • Las inmunoterapias como los anticuerpos anti-PD1/anti-PDL1 ofrecen altas tasas de respuesta y resultados duraderos.
  • Los biomarcadores predictivos para la eficacia del tratamiento siguen siendo escurridizos, a pesar de algunas asociaciones con la terapia adyuvante.

Conclusiones:

  • El pronóstico del melanoma metastásico sigue siendo pobre a pesar de los avances terapéuticos.
  • Las terapias combinadas y las nuevas inmunoterapias son prometedoras, pero requieren más investigación.
  • La identificación de biomarcadores confiables es crucial para optimizar el tratamiento del melanoma y predecir los resultados de los pacientes.